Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × OTHER × pCR Rate × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 709 Neoplasms 456 Prostatic Neoplasms 389 Carcinoma, Non-Small-Cell Lung 384 Lung Neoplasms 308 Leukemia, Myeloid, Acute 298 Multiple Myeloma 266 Colorectal Neoplasms 240 Neoplasm Metastasis 239 Leukemia 234 Pancreatic Neoplasms 233 Melanoma 213 Lymphoma 213 Precursor Cell Lymphoblastic Leukemia-Lymphoma 202 Brain Neoplasms 191 Recurrence 177 Head and Neck Neoplasms 177 Lymphoma, Non-Hodgkin 172 Leukemia, Lymphocytic, Chronic, B-Cell 167 Myelodysplastic Syndromes 166 Ovarian Neoplasms 157 Carcinoma, Hepatocellular 149 Glioblastoma 146 Carcinoma, Renal Cell 136 Rectal Neoplasms 132 Colonic Neoplasms 129 Lymphoma, Large B-Cell, Diffuse 124 Lymphoma, Follicular 123 Hodgkin Disease 115 Squamous Cell Carcinoma of Head and Neck 107

Interventions

Metformin 1 Epirubicin 1 Docetaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01929811 2022-04-06

NeoMET

Shanghai Jiao Tong University School of Medicine

Phase 2 Terminated

pCR Rate

Data powered by HemOnc (CC BY 4.0) Colophon ⚡